<DOC>
	<DOC>NCT01452347</DOC>
	<brief_summary>To validate the dosing algorithm for dabigatran etexilate in patients receiving a mechanical heart valve.</brief_summary>
	<brief_title>Dabigatran Etexilate in Patients With Mechanical Heart Valves</brief_title>
	<detailed_description />
	<mesh_term>Heart Valve Diseases</mesh_term>
	<mesh_term>Dabigatran</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Inclusion criteria: 1. Patients aged 1875 2. Patients who have received a bileaflet mechanical heart valve Exclusion criteria: 1. Prior valve surgery 2. Uncontrolled hypertension 3. severe renal impairment 4. active liver disease 5. increased risk of bleeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>